David Ulmert

David Ulmert

Company: University of California Los Angeles

Job title: Director, Preclinical Theranostics Program at UCLA


LRRC15-Targeted Radiotheranostic Strategies to Overcome TGFB-Driven Treatment Resistance in Cancer 4:00 pm

Exploring novel strategies for overcoming radioresistance Outlining novel target Applications to broader therapiesRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.